SEHK:1789

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally.


Snowflake Analysis

Exceptional growth potential with solid track record.


Similar Companies

Share Price & News

How has AK Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 1789's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-6.0%

1789

4.0%

HK Medical Equipment

1.2%

HK Market


1 Year Return

352.2%

1789

227.7%

HK Medical Equipment

5.5%

HK Market

Return vs Industry: 1789 exceeded the Hong Kong Medical Equipment industry which returned 227.7% over the past year.

Return vs Market: 1789 exceeded the Hong Kong Market which returned 5.5% over the past year.


Shareholder returns

1789IndustryMarket
7 Day-6.0%4.0%1.2%
30 Day-21.0%-3.7%-3.8%
90 Day-2.1%52.2%7.7%
1 Year353.8%352.2%229.8%227.7%9.8%5.5%
3 Yearn/a212.4%203.8%3.7%-7.4%
5 Yearn/a307.4%288.3%12.3%-6.5%

Price Volatility Vs. Market

How volatile is AK Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is AK Medical Holdings undervalued compared to its fair value and its price relative to the market?

74.71x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 1789 (HK$21.3) is trading above our estimate of fair value (HK$15.42)

Significantly Below Fair Value: 1789 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 1789 is poor value based on its PE Ratio (74.7x) compared to the HK Medical Equipment industry average (51.1x).

PE vs Market: 1789 is poor value based on its PE Ratio (74.7x) compared to the Hong Kong market (10.3x).


Price to Earnings Growth Ratio

PEG Ratio: 1789 is poor value based on its PEG Ratio (2.3x)


Price to Book Ratio

PB vs Industry: 1789 is overvalued based on its PB Ratio (18.1x) compared to the HK Medical Equipment industry average (4.2x).


Next Steps

Future Growth

How is AK Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

32.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1789's forecast earnings growth (32% per year) is above the savings rate (1.6%).

Earnings vs Market: 1789's earnings (32% per year) are forecast to grow faster than the Hong Kong market (18.7% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1789's revenue (26.3% per year) is forecast to grow faster than the Hong Kong market (11.4% per year).

High Growth Revenue: 1789's revenue (26.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1789's Return on Equity is forecast to be high in 3 years time (28.1%)


Next Steps

Past Performance

How has AK Medical Holdings performed over the past 5 years?

30.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 1789 has a high level of non-cash earnings.

Growing Profit Margin: 1789's current net profit margins (28.8%) are higher than last year (24.1%).


Past Earnings Growth Analysis

Earnings Trend: 1789's earnings have grown significantly by 30.6% per year over the past 5 years.

Accelerating Growth: 1789's earnings growth over the past year (84.2%) exceeds its 5-year average (30.6% per year).

Earnings vs Industry: 1789 earnings growth over the past year (84.2%) exceeded the Medical Equipment industry 16%.


Return on Equity

High ROE: 1789's Return on Equity (23.9%) is considered high.


Next Steps

Financial Health

How is AK Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: 1789's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥327.9M).

Long Term Liabilities: 1789's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥38.3M).


Debt to Equity History and Analysis

Debt Level: 1789's debt to equity ratio (0.2%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if 1789's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: 1789's debt is well covered by operating cash flow (8509.5%).

Interest Coverage: 1789 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Next Steps

Dividend

What is AK Medical Holdings's current dividend yield, its reliability and sustainability?

0.35%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 1789's dividend (0.35%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.29%).

High Dividend: 1789's dividend (0.35%) is low compared to the top 25% of dividend payers in the Hong Kong market (6.87%).


Stability and Growth of Payments

Stable Dividend: 1789 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.

Growing Dividend: 1789 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.


Current Payout to Shareholders

Dividend Coverage: 1789 is not paying a notable dividend for the Hong Kong market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 1789's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Zhijiang Li (52 yo)

no data

Tenure

CN¥1,490,000

Compensation

Mr. Zhijiang Li serves as Chairman and Chief Executive Officer at AK Medical Holdings Limited. Mr. Li is responsible for the overall strategic planning and development of at AK Medical Holdings Limited. Mr ...


CEO Compensation Analysis

Compensation vs Market: Zhijiang's total compensation ($USD213.84K) is below average for companies of similar size in the Hong Kong market ($USD498.20K).

Compensation vs Earnings: Zhijiang's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Zhijiang Li
Chairman & CEOno dataCN¥1.49m45.35%
CN¥ 10.8b
Xiaohong Zhao
CFO & Executive Director4.5yrsCN¥2.52m0.090%
CN¥ 21.3m
Bin Zhang
Senior VP & Executive Director5.08yrsCN¥306.00k0.91%
CN¥ 215.7m
Chaoyang Zhang
Senior VP & Executive Director5.08yrsCN¥1.12m5.28%
CN¥ 1.3b
Weiping Zhang
Chief Engineer of Ak Medical Beijing11.67yrsno datano data
Sun Hongbo
Head of Production Centre of AK Medical Beijing3.67yrsno datano data
Yu Han
Joint Company Secretary4.33yrsno datano data
Yan Wing Li
Joint Company Secretary4.33yrsno datano data

4.3yrs

Average Tenure

51.5yo

Average Age

Experienced Management: 1789's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Zhijiang Li
Chairman & CEOno dataCN¥1.49m45.35%
CN¥ 10.8b
Xiaohong Zhao
CFO & Executive Director4.5yrsCN¥2.52m0.090%
CN¥ 21.3m
Bin Zhang
Senior VP & Executive Director5.08yrsCN¥306.00k0.91%
CN¥ 215.7m
Chaoyang Zhang
Senior VP & Executive Director5.08yrsCN¥1.12m5.28%
CN¥ 1.3b
David Wang
Non-Executive Director4.5yrsno datano data
Chi Mo Kong
Independent Non-Executive Director2.75yrsCN¥158.00kno data
Eric Wang
Independent Non-Executive Director0.17yrno datano data
Shu Wing Li
Independent Non-Executive Director2.75yrsCN¥158.00kno data

4.4yrs

Average Tenure

52yo

Average Age

Experienced Board: 1789's board of directors are considered experienced (4.4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 6.7%.


Top Shareholders

Company Information

AK Medical Holdings Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: AK Medical Holdings Limited
  • Ticker: 1789
  • Exchange: SEHK
  • Founded: 2003
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: HK$23.728b
  • Shares outstanding: 1.11b
  • Website: https://www.ak-medical.net

Number of Employees


Location

  • AK Medical Holdings Limited
  • Xingye Building
  • 2nd Floor
  • Beijing
  • Beijing Province
  • 102200
  • China

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
1789SEHK (The Stock Exchange of Hong Kong Ltd.)YesOrdinary SharesHKHKDDec 2017

Biography

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/08/08 12:34
End of Day Share Price2020/08/07 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.